Basket

Record was added to the basket

1.Ocrelizumab - anti CD20 terapia ako nový míľnik v liečbe sclerosis multiplex

Ocrelizumab - anti CD20 terapia ako nový míľnik v liečbe sclerosis multiplex / Viera Hančinová . Nové lieky : časopis o liekoch. - ISSN 1339-8091 . - Roč. 6, č. 5 (2019), s. 18-24 : ilustr., fareb., grafy, obr., tab.

C 3177
Request a copy DDS
DSD service
From the basket
Citation
Bookmark

Selected documents
Citation

citace PRO
article

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.